[Chemotherapy of bronchila cancer. Monotherapy and combination therapy].
D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001984:Bronchial Neoplasms / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D003581:Cytodiagnosis; D003937:Diagnosis, Differential; D003967:Diarrhea / Q000209:etiology; D004357:Drug Synergism; D006801:Humans; D007275:Injections, Intravenous; D007970:Leukopenia / Q000209:etiology; D008297:Male; D008875:Middle Aged; D009325:Nausea / Q000209:etiology; D008517:Phytotherapy; D010946:Plants, Medicinal; D010947:Plants, Toxic; D011033:Podophyllin / Q000008:administration & dosage / Q000009:adverse effects; D011035:Podophyllum / Q000008:administration & dosage* / Q000009:adverse effects; D011859:Radiography; D013607:Tablets; D014228:Triaziquone / Q000008:administration & dosage* / Q000009:adverse effects
D000970:Antineoplastic Agents; D013607:Tablets; D003520:Cyclophosphamide; D011033:Podophyllin; D014228:Triaziquone
Chemotherpie des Bronchilkrebses. Monotherapie und Kombinationstherapie.